Skip to content

Glycemic and Metabolic Responses of Frozen Yogurt Containing Saskatoon Berry Powder in Healthy Males and Females

A Randomized, Controlled Study to Examine the Glycemic and Metabolic Responses of Frozen Yogurt Containing Saskatoon Berry Powder in Healthy Males and Females

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02571114
Enrollment
13
Registered
2015-10-08
Start date
2015-10-31
Completion date
2016-06-30
Last updated
2016-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Glycemic Responses, Metabolic Responses, Males, Females

Brief summary

A single site, blinded, randomized, controlled study designed to examine the glycemic and metabolic response of frozen yogurt containing Saskatoon berry powder in healthy males and females.

Detailed description

A single site, blinded, randomized, controlled study designed to examine the glycemic and metabolic response of frozen yogurt containing Saskatoon berry powder in healthy males and females. Eligible participants will be asked to attend 4 in-person clinic visits for comparative testing of the frozen yogurt and frozen yogurt containing Saskatoon berry powder versus white bread. Separate visits for screening and for a fasting blood sample will also be requested (total of 6 visits).

Interventions

DIETARY_SUPPLEMENTSaskatoon Berry Frozen Yogurt

Frozen yogurt containing a defined amount of powder prepared from Saskatoon berries (serving size = 25 g available carbohydrate)

DIETARY_SUPPLEMENTFrozen Yogurt

Unflavoured frozen yogurt (serving size = 25 g available carbohydrate)

DIETARY_SUPPLEMENTControl 1

White bread (serving size = 25 g available carbohydrate)

DIETARY_SUPPLEMENTControl 2

White bread (serving size = 25 g available carbohydrate)

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male, or non-pregnant, non-lactating female, ≥18 and ≤35 years; 2. Normal blood lipid profile, creatinine \<1.5× upper limit of normal (ULN) where the normal range is ≥7 units/L and ≤56 units/L, alanine aminotransferase (ALT) \<2× ULN where the normal range is ≥0.7 mg/dL and ≤1.3 mg/dL, and glycated hemoglobin \<6%; 3. Blood pressure \<140/90 4. Body mass index (BMI) ≥20 and \<30; 5. Stable regime for the past 3 months if taking vitamin and mineral/dietary/ herbal supplements; 6. Agree not to eat Saskatoon berries or foods containing Saskatoon berries while participating in this study; 7. Willing to comply with the protocol requirements; 8. Willing to provide informed consent.

Exclusion criteria

1. Not able to consume yogurt or allergies to Saskatoon berries or ingredients in yogurt or bread; 2. Presence of a clinically diagnosed disease affecting the circulatory, respiratory, immune, skeletal, urinary, muscular, endocrine, digestive, nervous or reproductive system that requires medical treatment; 3. Taking any prescribed medication in the last 3 months or supplements that affect gastrointestinal function in the last 3 months; 4. Weight loss of ≥3 kg of body weight within the 6 months prior to enrolling in the study; 5. Current (within the last month) bacterial, viral or fungal infection, or over-the-counter medication within the past 72 hours; 6. Unable to obtain blood samples at the screening or the first study visit.

Design outcomes

Primary

MeasureTime frameDescription
Serum glucose180 minglucometer readings of serum glucose at intervals after consumption of study foods

Secondary

MeasureTime frameDescription
serum insulin180 minserum insulin levels in response to consumption of study foods
metabolomics180 minmass spectrometry analysis of serum and urine before and after consumption of study foods

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026